The solution effectively cleans and disinfects our contact lenses, while also providing up to 20 hours of moisture for all-day comfort. We appreciate the multi-purpose nature of the solution ...

LUMIFY eye drops were initially introduced by Bausch + Lomb in 2018 and remain the only OTC redness relievers that ...

Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know Radek Strnad Tue, May 27, 2025, 12:47 PM 3 min read ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of LUMIFY Preservative Free ...

Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 21.2% in the morning session after the company reported weak first quarter 2025 results: constant currency revenue fell short of Wall ...

The FDA elevated a recall of intraocular lenses currently being wrapped up by Bausch + Lomb, following increased reports of inflammatory reactions from patients who underwent cataract surgery.

Innovations in 170-year-old Bausch + Lomb’s pipeline include a biomimetic contact lens, a myopia control solution for children and revamped pharmaceutical products targeting unmet eye health needs.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chief Financial Officer Sam Eldessouky ...

With updated guidance reflecting stable long-term growth prospects, Bausch + Lomb is positioned to leverage its premium IOL pipeline and dry eye portfolio while navigating external pressures such ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chief ...

and such report will be made available on the Company’s SEDAR+ profile and on the Company’s website at www.bausch.com.